JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $86,481 | $59,460 | $7,192,000 | $9,223,000 |
| % Growth | 45.4% | -99.2% | -22% | – |
| Cost of Goods Sold | $13,554 | $16,619 | $4,326,000 | $2,677,000 |
| Gross Profit | $72,927 | $42,841 | $2,866,000 | $6,546,000 |
| % Margin | 84.3% | 72.1% | 39.8% | 71% |
| R&D Expenses | $30,332 | $23,232 | $15,431,000 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $22,673 | $6,818,000 | $6,669,000 | $6,561,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$6,793,922 | -$13,338,000 | $0 |
| Operating Expenses | $53,005 | $47,310 | $8,762,000 | $6,561,000 |
| Operating Income | $19,922 | -$4,469 | -$5,896,000 | -$15,000 |
| % Margin | 23% | -7.5% | -82% | -0.2% |
| Other Income/Exp. Net | $2,332 | -$742 | -$199,000 | $253,000 |
| Pre-Tax Income | $22,254 | -$5,211 | -$6,095,000 | $238,000 |
| Tax Expense | $6,848 | -$1,249 | $1,878,000 | $36,000 |
| Net Income | $15,251 | -$546,000 | -$4,183,000 | $115,000 |
| % Margin | 17.6% | -918.3% | -58.2% | 1.2% |
| EPS | 0.13 | -4.48 | -34.28 | 0.93 |
| % Growth | 102.9% | 86.9% | -3,786% | – |
| EPS Diluted | 0.13 | -4.48 | -34.28 | 0.93 |
| Weighted Avg Shares Out | 121,888 | 121,845 | 122,035 | 123,245 |
| Weighted Avg Shares Out Dil | 121,942 | 121,845 | 122,035 | 121,825 |
| Supplemental Information | – | – | – | – |
| Interest Income | $196 | $0 | $0 | $0 |
| Interest Expense | $527 | $17,000 | $30,000 | $0 |
| Depreciation & Amortization | $4,874 | $843,500 | $843,500 | $799,250 |
| EBITDA | $27,635 | $199,500 | -$5,100,500 | $739,250 |
| % Margin | 32% | 335.5% | -70.9% | 8% |